My ePortfolio Register   
 

Abstract | Full HTML Article | PDF ecancer 10 610 / DOI: 10.3332/ecancer.2016.610

Clinical Study

Repurposing Drugs in Oncology (ReDO)—diclofenac as an anti-cancer agent

Diclofenac (DCF) is a well-known and widely used non-steroidal anti-inflammatory drug (NSAID), with a range of actions which are of interest in an oncological context. While there has long been an interest in the use of NSAIDs in chemoprevention, there is now emerging evidence that such drugs may have activity in a treatment setting. DCF, which is a potent inhibitor of COX-2 and prostaglandin E2 synthesis, displays a range of effects on the immune system, the angiogenic cascade, chemo- and radio-sensitivity and tumour metabolism. Both pre-clinical and clinical evidence of these effects, in multiple cancer types, is assessed and summarised and relevant mechanisms of action outlined. Based on this evidence the case is made for further clinical investigation of the anticancer effects of DCF, particularly in combination with other agents - with a range of possible multi-drug and multi-modality combinations outlined in the supplementary materials accompanying the main paper.

Keywords: Drug repurposing, diclofenac, NSAID, perioperative intervention, ReDO project

Loading Article Metrics ... Please wait

Related articles

Special Issue: Integration of legal aspects and human rights approach in palliative care delivery—The Nyeri hospice model

Abstract | Full Article | PDF Published: 07 Jul 2016 / DOI: 10.3332/ecancer.2016.656

Special Issue: Interventions geared towards strengthening the health system of Namibia through the integration of palliative care

Abstract | Full Article | PDF Published: 07 Jul 2016 / DOI: 10.3332/ecancer.2016.653

Special Issue: Best practices in developing a national palliative care policy in resource limited settings: lessons from five African countries

Abstract | Full Article | PDF Published: 07 Jul 2016 / DOI: 10.3332/ecancer.2016.652

Review: Targeted therapies and immunotherapy in non-small-cell lung cancer

Abstract | Full Article | PDF Published: 23 Jun 2016 / DOI: 10.3332/ecancer.2016.648

Conference Report: Highlights from the Tenth European Breast Cancer Conference (EBCC10), Amsterdam, 9–11 March 2016

Abstract | Full Article | PDF Published: 03 Jun 2016 / DOI: 10.3332/ecancer.2016.644



Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

Cancer Intelligence